United States: He Who Does Not Hesitate Is Lost When Pleading Demand Futility

Last Updated: October 1 2014
Article by Alexander D. Widell

Criminal and civil enforcement proceedings against corporations show no sign of abating, and the penalties, fines and settlements associated with such proceedings can be staggering. Last month, Goldman Sachs agreed to pay the Federal Housing Finance Administration $1.2 billion to settle litigation arising out of the fraudulent sale of mortgage-backed securities. In June of this year, BNP Paribas agreed to plead guilty and pay $8.9 billion in penalties for illegally processing financial transactions for countries subject to U.S. economic sanctions. In May, Credit Suisse pleaded guilty to conspiracy to assist U.S. taxpayers in filing false income tax returns with the Internal Revenue Service, and agreed to pay a fine of $2.6 billion; and last year, Johnson & Johnson paid $2.2 billion to resolve criminal and civil charges arising out of its marketing of prescription drugs for off-label uses.

Derivative lawsuits driven by specialized shareholder law firms, aimed at a corporation's individual directors, often follow in the wake of criminal and civil enforcement proceedings and the multibillion-dollar payments to resolve those proceedings. The precipitous filing of such lawsuits, however, without a proper factual investigation of the board's knowledge and involvement in the liability-causing conduct can doom the lawsuit from the beginning and lead to an early and permanent dismissal. One important, but often overlooked and underused, pre-suit investigatory tool is a books and records demand, which provides "behind the scenes" access to a corporation's nonpublic documents.

Because directors, rather than shareholders, manage the business and affairs of the corporation, shareholders are generally not permitted to bring a lawsuit on behalf of a corporation unless they first make a demand on the board of directors to take action, and the board refuses to so act. An exception exists, however, where a pre-suit demand on the board would be futile because at least half of its members face a substantial likelihood of personal liability for participation in the underlying alleged wrongdoing. In order to establish such directorial liability in cases involving criminal or regulatory misconduct, shareholders' counsel must plead and prove that the board either intentionally caused the corporation to engage in unlawful conduct, permitted unlawful conduct to continue by failing to act in the face of "red flags," or completely abdicated their duty to be active monitors of the corporation's performance.1

A law firm's ability to draft a complaint that successfully pleads such conduct—and, therefore, "demand futility"—has proven difficult because the facts required to prove directorial liability are typically not contained in publicly available documents, but rather, in internal corporate documents, such as minutes of board meetings, board presentations, email communications between the board and management, and communications with regulatory agencies.

A books and records demand can provide a law firm with access to such internal documents and the information it needs to adequately plead "demand futility" and defeat a motion to dismiss. Unfortunately, because of the potential for significant legal fees that are available to derivative shareholder's counsel who control the litigation, specialized shareholder law firms often race to the courthouse to be the first to file a lawsuit immediately upon the announcement of a government investigation or payment of an astronomical penalty, yet they fail to conduct any investigation to determine whether a pre-suit demand on the board of directors is excused as futile. Two important opinions issued by the Delaware Court of Chancery illustrate the risks a shareholder takes by hurriedly filing a derivative action without conducting a pre-suit investigation.

'South v. Baker'

South v. Baker, 62 A.3d 1, 16 (Del. Ch. 2012), arose out of a series of serious accidents, some fatal, that occurred at a mine owned and operated by Hecla Mining Company. In January 2012, the U.S. Mine Safety and Health Administration (MSHA) issued a press release that contained the results of its inspections of Hecla, which included 59 citations for violating safety standards. Hecla, too, issued a press release that announced that MSHA had ordered the company to close part of the mine, resulting in a lowered projection of its estimated silver production in 2012. The press releases prompted a race to the courthouse, which included two federal securities actions and seven derivative actions. All of the derivative actions sought to hold Hecla's individual directors liable for losses to the company.

In the one derivative action that was brought in Delaware, the shareholders neither sought to inspect Hecla's books and records prior to commencing the lawsuit, nor made a pre-suit demand on Hecla's board of directors to institute litigation to recover the company's losses. In granting the director-defendants' motion to dismiss the action based on plaintiffs' failure to allege that the pre-suit demand on the board was excused as futile, the court held that plaintiffs failed to allege facts supporting any of the actionable connections between the mining accidents and the board of directors.

In so doing, the court indicated where a pre-suit inspection of Hecla's books and records may have resulted in a different outcome. For example, plaintiffs did not allege any facts from which it could be inferred that the directors consciously violated a statute, regulation or other law. The court noted that instead of looking for such evidence by exercising their right to inspect the corporation's minutes and other documents from board and safety committee meetings, they chose instead to rely on publicly available documents that discussed day-to-day operational issues, rather than board-level decisions.2

The court also rejected plaintiffs' assertion that the board exhibited a conscious indifference in the face of red flags—i.e., the series of accidents at the mine—by continuing to ignore the safety issues at the mine. The court stated that "the complaint nowhere alleges anything that the directors were told about the incidents, what the board's response was, or even that the incidents were connected in any way." In providing guidance to future litigants, the court stated: "Here again, [plaintiffs] might have used [a books and records inspection] to investigate what the directors knew and did, evaluate their theories of liability, and make an informed decision about whether or not to sue."

Based on plaintiffs' failure to plead particularized facts to support a reasonable inference that a majority of the board faced a substantial risk of liability, the court dismissed the complaint for failure to plead demand futility.

'Louisiana Mutual'

Another recent case, Louisiana Municipal Police Employees' Retirement System v. Pyott, 46 A.3d 313 (Del. Ch. 2012), tells a much different story, and well-illustrates the benefits that can be obtained by not rushing to the courthouse and, instead, conducting a pre-suit investigation of internal corporate documents. That case involved Allergan, Inc., the company that manufactures the muscle relaxant Botox.3 On Sept. 3, 2010, Allergan pleaded guilty to claims of misbranding and off-label marketing of Botox from 2000-2005, and agreed to pay $600 million in criminal and civil fines to the U.S. Department of Justice. Two days later, the Louisiana Municipal Police Employees' Retirement System (LAMPERS) filed a derivative action in Delaware against Allergan's directors based solely on publicly available information.

Meanwhile, on Nov. 3, 2010, UFCW Local 1776 & Participating Employers Pension Fund (UFCW), another shareholder of Allergan, sent Allergan a demand to inspect its books and records. After having obtained the documents it demanded, including written strategic plans and detailed presentations made at board of directors' meetings, UFCW intervened as a plaintiff in the action and, with LAMPERS, filed a new complaint. Because neither of the plaintiffs made a pre-suit demand on Allergan's board of directors, they were required to allege that demand was excused as futile because at least half of the board faced a substantial risk of liability.

Plaintiffs sought to hold Allergan's directors responsible for the company's unlawful activity based on allegations that the board itself, and not employees deep within the organization, affirmatively and consciously set out to violate the laws against off-label marketing of pharmaceuticals. Despite the historical difficulty shareholders have had in successfully alleging facts to support such an intent-based theory of liability, plaintiffs were able to do so based on the documents they obtained pursuant to UFCW's books and records demand.

For example, UFCW obtained a slide presentation and versions of written strategic plans that were provided to the board that summarized Allergan's plan to increase sales of Botox for off-label uses. One of the slides in the presentation showed that a "top corporate priority" of Allergan was to "maximize new products." One of those products was Botox, which the presentation stated could be used to treat "spasticity, migraine and pain," uses that had not been FDA-approved and were therefore "off-label."

Another slide describing the "charter" for the Botox "business portfolio strategy" showed a plan by Allergan to devote resources to "grow new indications and develop follow-on toxins," and again identified spasticity, back pain and headache as uses for Botox. The written strategic plans that UFCW obtained through their inspection provided further support for plaintiffs' allegations that Allergan's board affirmatively knew of and approved the company's plan for explosive growth in Botox sales through the marketing and promotion of the drug for off-label uses.

One section of a strategic plan stated that "[i]nvestments in new indications of pain and migraine headache represent two of the top three future growth opportunities in our portfolio with combined peak year sales of $1.26 billion!" Consistent with the discussions in the presentation slides, Allergan's written strategic plans contemplated that the company would enter both the migraine headache and back pain markets, and contemplated marketing plans and programs to promote such off-label use.

Allergan's internal documents provide plaintiffs facts that allowed them to allege with factual specificity that Allergan's board regularly monitored Botox sales and the revenue generated from different categories of Botox use. Reports reviewed by the board showed that between 2000 and 2004, Botox sales grew between 25 and 42 percent, even though Botox had only been approved for four uses where demand was limited. Because off-label sales of Botox for spasticity, headache and pain grew by an average of 750 percent, the court held that, at the pleading stage, it was reasonable to infer that the board knew that it was unlikely that physicians were independently supporting off-label uses in the same areas that Allergan was targeting pursuant to its strategic growth plan. Accordingly, the court denied defendants' motion to dismiss for failure to plead demand futility.

Pleading Demand Futility

A shareholder's failure to adequately plead demand futility may forever preclude the company's other shareholders from pursuing a derivative action to redress the same misconduct— even those shareholders who conduct a books and records inspection and obtain facts that allow them to adequately plead demand futility. In Louisiana Municipal, defendants argued in the Chancery Court that the shareholder plaintiffs should be collaterally estopped from alleging demand futility because a California federal court had earlier dismissed a derivative action brought by a different shareholder based on his failure to adequately plead demand futility.

In rejecting defendants' collateral estoppel argument, the Chancery Court held that where a plaintiff rushes to file a lawsuit prior to conducting a factual investigation, and as a result fails to adequately plead demand futility, a presumption exists that the plaintiff is not an adequate fiduciary because he is serving the financial interests of the law firm that filed the lawsuit, rather than the best interests of the corporation. In the absence of a finding of adequacy, the shareholder's actions are not binding on the corporation's other shareholders.

The Delaware Supreme Court, however, rejected the Chancery Court's "'fast filer' irrebuttable presumption of inadequacy."4 In so doing, the court stated that "there is no record support for the trial court's premise that stockholders who file quickly, without bringing a §220 books and records action, are a priori acting on behalf of their law firms instead of the corporation." Because there was no factual basis on which to conclude that the plaintiffs in the California derivative action were inadequate, the Supreme Court reversed the Chancery Court's judgment denying defendants' motion to dismiss on collateral estoppel grounds.


Derivative lawsuits are an important mechanism in a corporation's ability to recover losses stemming from directorial misconduct. However, for the device to serve its intended purpose, specialized shareholder law firms must resist the economically driven impulse to file a derivative suit immediately upon the heels of a criminal investigation or regulatory enforcement proceeding.

Because directorial liability is usually difficult to plead solely from publicly available information, shareholders and their counsel should avail themselves of their right to inspect the corporation's internal books and records. If shareholders do not conduct such an investigation and leap to litigate without first providing the board of directors with an opportunity to take action on behalf of the corporation, the director defendants will likely be able to end the lawsuit in the earliest stages because of plaintiff's inability to adequately allege demand futility. Such a race to the courthouse and resulting hastily filed lawsuit may not only have an adverse impact on the very corporation shareholder counsel is purporting to represent, but may also prevent different shareholders who do conduct a pre-suit investigation from pursuing claims arising out of the same misconduct.

Originally published by New York Law Journal.


1. See In re Caremark International Inc. Deriv. Litig., 698 A.2d 959 (Del. 1996).

2. South v. Baker, Case No. 7294-VCL, 2012 WL 4372538, at **10-11 (Del. Ch. Sept. 25, 2012).

3. See Louisiana Municipal Police Employees' Retirement System v. Pyott, 46 A.3d 313 (Del. Ch. 2012).

4. 74 A.3d 612 (Del. 2013).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Alexander D. Widell
In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement

    Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of www.mondaq.com

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at enquiries@mondaq.com.

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions